HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE

Catalog No:
MBL-TS-M123-1
$1,470.00

Description

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence FLRGRAYGL
Class Class I
Sequence Location 325-333
MHC Allele B*08:01

Documents & Links

Documents & Links for HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE
Datasheet HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE Datasheet

Documents & Links for HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE
Datasheet HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE Datasheet

Product Description

The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.

Product Specifications

Product Specifications
Application FC
Reactivity Human
Conjugation PE
Peptide Sequence FLRGRAYGL
Class Class I
Sequence Location 325-333
MHC Allele B*08:01

Documents & Links

Documents & Links for HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE
Datasheet HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE Datasheet

Documents & Links for HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE
Datasheet HLA-B*08:01 EBV EBNA3A Tetramer-FLRGRAYGL-PE Datasheet